Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
December 2016 onwards
Submit An Event
Events - October 2012
Indian Lab Automation 2012
30 Oct 2012 - 31 Oct 2012 - Mumbai, India
This conference will amalgamate the cutting-edge techniques used by leading research institutes. With access to all three tracks, Drug Discovery & Development, Advances in Genomics & Informatics and Advances in Bioanalysis, this conference aims to provide delegates with a comprehensive overview of the essential techniques required to investigate current scientific advancements.
The Flow Chemistry workshop will be taking place prior to this conference.
Drug Discovery & Development
In the ever-expanding field of drug development it is vital for scientists to remain at the forefront of drug discovery and refinement in order to keep up with consumerist demand. With a need for improved specificity and fewer side-effects in patients, our speakers will be discussing the sophisticated details of the fundamental techniques required to develop the most successful drugs.
This branch of analytical chemistry is essential in obtaining accurate quantitative measurements of drug metabolites and macromolecules. Keynote presentations will talk about innovative analytical methods, explain their movement towards a more reliable, rational approach of analysis, and describe the considerable impact these techniques can have on the overall success of pharmaceutical research.
Advances in Genomics and Informatics
Despite the remarkable feat of sequencing the human genome nearly ten years ago, the sheer volume of information that DNA provides us with requires continual advancements in the way we unravel and analyse the data. Our speakers will address numerous methods of analysis, particularly focusing on the exciting areas of epigenetics, miRNA and Next-Gen Sequencing.
For more information on the stimulating research involved in epigenetics, miRNA and Next-Gen Sequencing, please view the information on the Genomics Research Asia conference being held later this year.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Cell Cargo Ships in Near Future?
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Unravelling the Roots of Insect’s Waterproof Coating
Researchers have identified the genes that control cuticular lipid production in Drosophila, by performing an RNAi screen and using Direct Analysis in Real Time and GC-MS.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,200+ scientific and medical posters
4,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!